Cardiol Therapeutics Inc. Class A Common Shares (CRDL)
search
Earnings reactions
How CRDL moved on each past earnings report.
Up
Down
Earnings Impact
Cardiol Therapeutics Inc. Class A Common Shares (CRDL) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
Historical Earnings Statistics
Cardiol Therapeutics Inc. Class A Common Shares (CRDL) has no earnings-reaction history on record — it does not report quarterly earnings (e.g. a fund, ETF, or other instrument), or is too newly listed to have a track record yet.
event
Earnings Count
0
Total earnings in dataset
trending_up
Avg Abs. Movement
±0.00%
Avg % price change on earnings
account_balance
View all 6 →
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
6
Funds holding
$796082
Total value held
Buying
4 added · 1 reduced
Morgan Stanley
$376332
+41.77%
Goldman Sachs Group Inc
$353934
+0.45%
Jpmorgan Chase & Co
$49519
Held
Ubs Group Ag
$8979
NEW BUY
Royal Bank Of Canada
$7000
-68.92%
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 6-K | 20260923 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260923 | open_in_new SEC.gov |
| 6-K | 20260916 | open_in_new SEC.gov |
| F-10/A | 20260916 | open_in_new SEC.gov |
| SUPPL | 20260916 | open_in_new SEC.gov |
| 6-K | 20260915 | open_in_new SEC.gov |
| 6-K | 20260911 | open_in_new SEC.gov |
| 6-K | 20260910 | open_in_new SEC.gov |
| F-10 | 20260910 | open_in_new SEC.gov |
| F-X | 20260910 | open_in_new SEC.gov |